Speaker Profile

Ph.D., Director of Business Development, NuProbe, USA

Biography
Nicolas Garreau de Loubresse, Ph.D., serves as Director of Business Development for NuProbe, USA. Previously, he was a Research Fellow at the Wyss Institute at Harvard University and a Business Development Fellow at Harvard Office of Technology Development. He is also the co-founder of Urania Therapeutics and inventor of Urania’s core technologies. He published first-author articles in Science and Nature, and received competitive fellowships (EMBO, HFSP) and awards (AXA-French Academy of Science).


Clinical & Research Tools Showcase:
NuProbe

NuProbe is a cutting-edge genomics and molecular diagnostics company with revolutionary technologies to improve the analytical sensitivity of DNA disease biomarkers.

Rapid Custom Development Program for Oncology Translational Research
• Ultrasensitive PCR and NGS assays for tissue and liquid biopsy applications
• Proprietary enrichment technology to increase sensitivity and lower sequencing requirements
• Comprehensive solutions for mutation, CNV, and fusion analysis
• Custom assays with a pathway to clinical trial application and CDx

 Session Abstract – PMWC 2022 Silicon Valley


The PMWC 2022 Clinical & Research Tools Showcase will provide a 15-minute time slot for selected companies in this space. The Clinical & Research Tools is a showcase for innovative technologies that are used for the analysis of genetic variation and function, helping to advance breakthroughs in genetic health, rare disease conditions on individuals of all ages, complex diseases and cancer care. Next-generation sequencing (NGS) and microarray technologies empower rapidly evolving genomic revolution.